PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Vibegron - Overactive bladder (adults)

PAD Profile : Vibegron - Overactive bladder (adults)

Keywords :
Over-active bladder, OAB, urinary frequency, urge incontinence, LUTS, lower urinary tract symptoms, urinary incontinence, urinary urgency
Brand Names Include :
Obgemsa

Traffic Light Status

Status 1 of 1.

Status :
Green (see narrative)
Important
Formulations :
  • Tablets
Important Information :
Mirabegron is the preferred option where an antimuscarinic is not suitable. Vibegron should have a very limited place in therapy.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NFD1
NICE
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
06 November 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approves vibegron as an option for treating the symptoms of overactive bladder (OAB) syndrome in adults.

Vibegron is only recommended if antimuscarinic medicines are not suitable, do not work well enough or have unacceptable side effects, as recommended by NICE in TA999.

Vibegron for this indication will be considered as GREEN on the traffic light system. Vibegron will be placed alongside mirabegron in the OAB pathway but mirabegron will be the preferred 1st line where both these two treatments may be suitable.

Vibegron does not have an identified place in therapy in preference to mirabegron.

 It was noted that vibegron has a BLACK triangle status with no evidence of advantages over Mirabegron, a well-established treatment, and it is therefore expected to have a very limited place in therapy in Surrey Heartlands ICB until more evidence becomes available

Associated BNF Codes

07. Obstetrics, Gynaecology and Urinary-Tract Disorders
07.04.02. Drugs for urinary frequency enuresis and incontinence
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More